In 1928, it was discovered that the x-ray machine (a fairly new technology at the time) could be used not only to see inside the body, but to destroy cancer cells as well. A few years later, Swedish Hospital founder Dr. Nils Johanson convinced trustees to build a cancer center, and purchase one of only eight supervoltage x-ray machines in the United States.
At the same time, Swedish also spent $30,000 on 500 milligrams of radium, another recently discovered therapy effective at killing malignant cells.
The Swedish Tumor Institute, established in 1932, became the first high-energy radiation therapy center west of the Mississippi, helping usher in the modern era of cancer treatment.
Since then, Swedish Cancer Institute has remained at the forefront of cancer care. In the 1960s and ’70s our institute led the way in surgery, chemotherapy and clinical trials. In the 1980s and ’90s our programs expanded to include several campuses and affiliate hospitals.
Over the past 10 years, Swedish Cancer Institute has moved forward with new innovations, such as the CyberKnife® and Gamma Knife®, breast and lung brachytherapy, robotic surgery, TomoTherapy and more.
As we prepare to enter our 80th year, we continue to expand our robust schedule of clinical trials, specialty programs, and roster of board-certified oncologists and surgeons to offer patients lifesaving cancer care and treatment.
In June 2012, we opened our state-of-the art True Family Women’s Cancer Center on the fourth and fifth floors of the Arnold Pavilion on the First Hill campus, where Swedish Cancer Institute (SCI) is headquartered. It is the Pacific Northwest’s largest, most comprehensive center devoted to treating cancers that affect women.
Schedule a conversation with a surgeon today!
HIPEC at Swedish Medical
What is HIPEC?
Hyperthermic intraperitoneal chemoperfusion (HIPEC) is a treatment option for advanced cancer that delivers an ultra-concentrated, heated chemotherapy solution directly to the abdomen during surgery. Our surgical oncologists have many years of experience offering this technique to patients with cancer in the abdominal cavity. SCI remains the only provider of HIPEC services in Western Washington.
Who is eligible for HIPEC?
HIPEC is best suited for patients who have cancers restricted to the abdomen. These patients may include those with pseudomyxoma peritoneii, colorectal, appendiceal, stomach, ovarian or primary peritoneal cancer. However, other conditions may benefit from this treatment. Talk with your provider about whether you might be a good candidate for HIPEC treatment.
How does HIPEC work?
HIPEC is a two-part surgery. The first part includes cytoreductive surgery, during which the surgeon makes an incision in the abdomen and removes as much visible tumor as possible.
The second part involves a set of in-flow and out-flow catheters that connect the abdomen to a perfusion machine, which circulates the heated solution. Chemotherapy is added to the solution in two doses over a 90-minute period. The chemotherapy solution flows into the abdomen and then back into the machine, where it is warmed before returning to the abdomen. During this process, the surgeon gently agitates the abdomen to help ensure that the chemotherapy solution reaches all abdominal organs. At the conclusion of therapy, the chemotherapy solution is drained and the abdomen is rinsed.
What are the advantages of HIPEC?
• HIPEC utilizes a higher dose of chemotherapy solution to ultimately help control the spread of cancer in the abdomen.
• Heat sensitizes cancer cells to chemotherapy.
• HIPEC allows for a more focused treatment by “bathing” abdominal cancers in chemotherapy.